Stay Current With Horse Health Defense

Don’t let new strains of equine influenza make you doubt your horse’s disease protection.

From AQHA Corporate Partner Zoetis

Equine influenza is a highly contagious respiratory disease that causes fever, coughing and nasal discharge.1 Treating it can cost you money. Recovery can cost you time away from training and competition.

The best method for helping to protect your horse against equine influenza virus is to vaccinate before exposure. But over time, new EIV strains can appear in circulation. So how can you trust that your horse is protected against the current EIV strains?

To support current protection, the World Organisation for Animal Health encourages vaccine manufacturers to work with laboratories that can test for reactivity against the current circulating strains.2 For this reason, Zoetis, manufacturer of the first EIV vaccine, FLUVAC INNOVATOR®, has partnered with the renowned Gluck Equine Research Center at the University of Kentucky.

Through this research, Zoetis continues its legacy of evaluating the FLUVAC INNOVATOR line of vaccines to help ensure the most relevant protection.3-7 In fact, the FLUVAC INNOVATOR vaccine line sets the standard for equine influenza vaccines with test studies against six EIV strains since 2002.3-7

Do you want to learn more about your horse's health and other topics? Subscribe to The American Quarter Horse Journal. You'll get new information every month in the mail or on your computer or mobile device.

Most recently, a serologic response study demonstrated an immune response with the FLUVAC INNOVATOR vaccine line against Richmond 07.7 Even though Richmond 07 is not circulating in the United States, it might be a threat to horses with international exposure; therefore Zoetis tested it against the FLUVAC INNOVATOR line of vaccines.

That’s why horse owners can depend on the FLUVAC INNOVATOR line of vaccines, which helps offer demonstrated protection against circulating EIV strains and know that Zoetis will continue to test and evaluate it.

After all, fever, coughing and nasal discharge aren’t the only causes of discomfort from EIV. There are those lost training days and the additional veterinary costs. In fact, the cost of EIV can reach up to $885 for an unvaccinated horse.*

The American Association of Equine Practitioners recommends vaccinating at-risk horses against EIV every six months.8 At-risk horses include those that are less than 6 years of age, geriatric horses and horses that may be frequently exposed to EIV at shows, trail rides or other events.8

The Zoetis commitment to providing an immunologically current EIV vaccine has made FLUVAC INNOVATOR the most trusted EIV line of vaccines, as well as the market leader.9

Now that you know more about protecting your horse from equine influenza, subscribe to The American Quarter Horse Journal to learn more about your horse's health and many other topics each month.

To ensure peace of mind, FLUVAC INNOVATOR vaccines are also backed by the Equine Immunization Support Guarantee from Zoetis. This guarantee provides up to $5,000 for reasonable diagnostic and treatment costs if a horse properly vaccinated by a veterinarian contracts the corresponding equine disease.

For more information on FLUVAC INNOVATOR, contact your veterinarian or visit Learn more about other Zoetis equine products at

*These costs are based on diagnostics, treatment and days of missed training based on the probability of mild, moderate or severe equine influenza in an unvaccinated horse.

This guarantee does not apply to, and Zoetis shall not be liable for, any (x) damages caused as a result of the improper handling, misuse or abuse of the vaccines that are the subject of this guarantee, or the willful misconduct or negligence of any third party, or (y) any indirect, punitive, special, incidental or consequential damages. Zoetis reserves the right to modify or cancel the terms and conditions of this guarantee.

1 Equine Influenza Vaccine Protocols: Boosters are best. Available at: Accessed July 9, 2014.
2 OIE expert surveillance panel on equine influenza composition. OIE Bulletin 2010;2:44-45.
3 Data on file, Study Report No. 671-02-001R, Zoetis Inc.
4 Data on file, Study Report No. 671-08-004.R, Zoetis Inc.
5 Data on file, Study Report No. 766-09-002.R, Zoetis Inc.
6 Data on file, Study Report No. 10OREQBIO-01, Zoetis Inc.
7 Data on file, Study Report No. 14OREQBIO-1, Zoetis Inc.
8 American Association of Equine Practitioners. Equine Influenza. Available at: Accessed July 9, 2014.
9 Data on file, MDI Sales Data from 2004-2013, Zoetis Inc.

All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors. ©2014 Zoetis Inc. All rights reserved.